Patient Selection for Sustaining Outcomes in the Pediatric Population with the t:slim X2 Insulin Pump with Control-IQ Technology

On October 13th, scientists and clinicians who have been closely involved in the development and launch of Control-IQ technology for the t:slim X2 insulin pump discussed patient selection and benefits in the pediatric population at the ISPAD 2021 Virtual Conference. Discussion included recent clinical data and patient-reported outcomes. Time was set aside at the end for a live question and answer session.